Cell-based Therapies

BioRestorative (BRTX) appointed Crystal Romano as Head of Global Commercial Operations on October 22, 2025. Romano brings 19 years of experience in medical aesthetics and regenerative industries, including a role at Cartessa where she helped commercialize 11 new products in under two years. The appointment aims to accelerate the commercialization of BioRestorative’s cell-based platforms, including BRTX-100, currently in Phase 2 trials, and unlock near-term revenue opportunities. Romano’s expertise is seen as a positive signal due to her experience in regulatory and commercial landscapes.